LGC Acquires The Native Antigen to Expand Product Offerings to IVD Sector.

MANews-(C)2009-2020

UK-based life sciences company LGC has acquired The Native Antigen company (NAC), a supplier of high quality infectious disease antigens and antibodies to strengthen product offerings to the IVD sector, the company said.

Terms of the transaction were not disclosed.

The acquisition includes a range of quality assurance tools, immunoassay reagents and disease state plasma as well as probes and primers for molecular diagnostics.

NAC's portfolio includes more than 60 viral and...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT